Department of Surgery, University of Calgary, Canada.
Department of Anesthesia, University of Calgary, Canada.
Surgery. 2023 Mar;173(3):653-658. doi: 10.1016/j.surg.2022.06.056. Epub 2022 Oct 22.
Pheochromocytomas produce excess catecholamines that can result in intraoperative hemodynamic instability. Centers have reported variations in intraoperative hemodynamics with the retroperitoneoscopic versus the laparoscopic transperitoneal approach to adrenalectomies. When the retroperitoneoscopic approach was initiated for pheochromocytomas at our institution, the perception was of improved intraoperative hemodynamics, hypothesizing that increased retroperitoneoscopic insufflation pressures caused decreased venous return and less fluctuation in circulating catecholamines. The purpose of this study was to examine if a difference in intraoperative hemodynamics exists between a size-matched cohort of laparoscopic transperitoneal and retroperitoneoscopic pheochromocytoma patients.
Unilateral adrenalectomies for pheochromocytoma performed via laparoscopic transperitoneal or retroperitoneoscopic approaches from 2015 to 2021 were identified from a surgical database. As larger tumors often underwent a laparoscopic transperitoneal approach, cases were matched 1:1 by tumor size. All patients received phenoxybenzamine. Groups were compared by patient characteristics, preoperative blockade, intraoperative hemodynamics and management, and early postoperative outcomes.
There were 13 laparoscopic transperitoneal adrenalectomy cases matched to 13 retroperitoneoscopic cases according to tumor size. Both groups (laparoscopic transperitoneal and retroperitoneoscopic) were similar for age (53 years), body mass index (28.5 vs 29.7), sex (69% female), and side (8 vs 7 right). There was no difference in preoperative 24-hour urine metanephrines/normetanephrines (9.9/8.0 vs 2.4/5.7 μmol/day). The phenoxybenzamine dose was similar in both groups (112 vs 114 mg/24 hours), as were baseline heart rate, blood pressure, and mean arterial pressure. There was no difference in any intraoperative hemodynamic parameters or vasoactive interventions. Operative time, length of stay, and 30-day emergency visits were similar between groups.
This matched cohort study did not find a difference in intraoperative hemodynamics between laparoscopic transperitoneal and retroperitoneoscopic adrenalectomy approaches for pheochromocytoma in appropriately selected and blocked patients.
嗜铬细胞瘤产生过量的儿茶酚胺,可导致术中血流动力学不稳定。各中心报告了经腹膜后腹腔镜与经腹腔腹腔镜肾上腺切除术之间术中血流动力学的变化。当我们医院开始采用经腹膜后腹腔镜入路治疗嗜铬细胞瘤时,人们认为术中血流动力学得到了改善,假设增加的经腹膜后腹腔镜充气压力会导致静脉回流减少,循环儿茶酚胺波动减少。本研究的目的是检查在大小匹配的腹腔镜经腹腔和经腹膜后腹腔镜嗜铬细胞瘤患者队列中是否存在术中血流动力学差异。
从手术数据库中确定了 2015 年至 2021 年间经腹腔镜经腹腔或经腹膜后腹腔镜单侧肾上腺切除术治疗的嗜铬细胞瘤病例。由于较大的肿瘤通常采用腹腔镜经腹腔入路,因此根据肿瘤大小对病例进行 1:1 匹配。所有患者均接受苯氧苄胺治疗。通过患者特征、术前阻断、术中血流动力学和管理以及术后早期结果比较两组。
根据肿瘤大小,共有 13 例腹腔镜经腹腔肾上腺切除术病例与 13 例经腹膜后腹腔镜病例相匹配。两组(腹腔镜经腹腔和经腹膜后腹腔镜)在年龄(53 岁)、体重指数(28.5 对 29.7)、性别(69%女性)和侧别(8 对 7 右)方面相似。术前 24 小时尿间甲肾上腺素/去甲肾上腺素(9.9/8.0 对 2.4/5.7 μmol/天)无差异。两组苯氧苄胺剂量相似(112 对 114mg/24 小时),基础心率、血压和平均动脉压也相似。术中血流动力学参数或血管活性干预无差异。手术时间、住院时间和 30 天急诊就诊率在两组间相似。
本匹配队列研究未发现在适当选择和阻断的患者中,腹腔镜经腹腔和经腹膜后腹腔镜肾上腺切除术治疗嗜铬细胞瘤的术中血流动力学存在差异。